The University of Miami Life Science & Technology Park has finalized four new leases for a combined 7,550 square feet of office and research and development space, growing occupancy to 63%. The park’s newest tenants are medical device firm Binder Biomedical, DemeRx, which is the first University of Miami spin-off to take space at the park, medical consulting firm Specialty Telehealth Services and the Miami-Dade Chamber of Commerce.
DemeRx is an innovative life sciences start-up company that is making breakthrough discoveries for the treatment of drug addiction among patients coping with chronic pain. The DemeRx clinical research program will pave the way toward developing a new class of non-addictive medications. Founded by University of Miami Miller School of Medicine professor of neurology Dr. Deborah Mash, DemeRx becomes the first University-affiliated company to locate in the UMLSTP’s first phase building.
Binder Biomedical, Inc. is a privately held medical device start-up founded in 2009 with the goal of combining quality engineering with surgeon innovation. The company, started in Boca Raton, is relocating its headquarters to the park, where it will occupy office space as well as research and development space at the Innovation Center, an accelerator space for start-up companies. Binder Biomedical currently provides surgeons with medical devices for the treatment of complex orthopedic and neurological spinal disorders.
Miami-Dade Chamber of Commerce, with more than 35 years serving the Miami community, advocates for the needs of the growing Black business community. From its new headquarters at the park, the organization will be able to continue to serve the business community and promote communication and networking for all its member businesses. Specialty Telehealth Services, which provides remote medical consulting services, is also moving into the park’s first building.